Health Catalyst, Inc. (NASDAQ:HCAT) Sees Large Increase in Short Interest

Health Catalyst, Inc. (NASDAQ:HCAT) saw a significant increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,840,000 shares, an increase of 8.8% from the October 15th total of 2,610,000 shares. Based on an average daily volume of 473,600 shares, the days-to-cover ratio is currently 6.0 days.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. JPMorgan Chase & Co. lifted their target price on shares of Health Catalyst from $10.00 to $13.00 and gave the company an “overweight” rating in a report on Wednesday, September 4th. Cantor Fitzgerald restated an “overweight” rating and issued a $16.00 price target on shares of Health Catalyst in a research note on Friday, October 4th. Evercore ISI increased their price objective on Health Catalyst from $8.00 to $10.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Stephens boosted their target price on shares of Health Catalyst from $7.00 to $9.00 and gave the stock an “equal weight” rating in a research report on Thursday. Finally, Royal Bank of Canada increased their price target on shares of Health Catalyst from $8.00 to $9.00 and gave the company a “sector perform” rating in a report on Thursday, November 7th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, Health Catalyst currently has a consensus rating of “Moderate Buy” and a consensus target price of $11.71.

Health Catalyst Trading Down 1.6 %

Shares of NASDAQ:HCAT traded down $0.12 during trading on Monday, reaching $7.53. The stock had a trading volume of 524,727 shares, compared to its average volume of 562,774. Health Catalyst has a fifty-two week low of $5.42 and a fifty-two week high of $11.41. The business has a fifty day moving average price of $8.16 and a 200-day moving average price of $7.23. The stock has a market cap of $458.19 million, a P/E ratio of -5.62 and a beta of 1.32. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.32.

Health Catalyst (NASDAQ:HCAT) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.07 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.03). Health Catalyst had a negative return on equity of 7.51% and a negative net margin of 26.20%. The business had revenue of $76.40 million for the quarter, compared to analysts’ expectations of $76.27 million. During the same period in the prior year, the company earned ($0.22) EPS. The company’s revenue for the quarter was up 3.5% compared to the same quarter last year. As a group, analysts anticipate that Health Catalyst will post -0.35 earnings per share for the current fiscal year.

Insider Buying and Selling at Health Catalyst

In other Health Catalyst news, insider Kevin Lee Freeman sold 7,500 shares of Health Catalyst stock in a transaction that occurred on Tuesday, September 3rd. The stock was sold at an average price of $7.22, for a total value of $54,150.00. Following the transaction, the insider now directly owns 255,881 shares in the company, valued at approximately $1,847,460.82. This trade represents a 2.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Daniel Lesueur sold 5,209 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $7.70, for a total value of $40,109.30. Following the sale, the chief operating officer now owns 129,690 shares of the company’s stock, valued at $998,613. This trade represents a 3.86 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,068 shares of company stock worth $257,555. 2.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Health Catalyst

A number of institutional investors have recently added to or reduced their stakes in the company. Primecap Management Co. CA lifted its holdings in shares of Health Catalyst by 14.7% during the 2nd quarter. Primecap Management Co. CA now owns 2,379,462 shares of the company’s stock valued at $15,205,000 after acquiring an additional 305,079 shares in the last quarter. Kennedy Capital Management LLC purchased a new stake in Health Catalyst during the 1st quarter worth approximately $8,780,000. Acadian Asset Management LLC raised its position in shares of Health Catalyst by 38.3% in the 1st quarter. Acadian Asset Management LLC now owns 724,560 shares of the company’s stock valued at $5,453,000 after purchasing an additional 200,494 shares in the last quarter. Janney Montgomery Scott LLC purchased a new position in shares of Health Catalyst during the 3rd quarter valued at approximately $897,000. Finally, Essex Investment Management Co. LLC acquired a new stake in shares of Health Catalyst during the third quarter worth approximately $2,012,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.